Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled study

Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids

(2012) Eugene R. Bleecker et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids

(2012) Jan Lötvall et al.   EUROPEAN RESPIRATORY JOURNAL

Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial

(2012) Eric D. Bateman et al.   RESPIRATORY MEDICINE

Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial

(2012) J Lötvall et al.   BMJ Open

Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial

(2011) William W Busse et al.   THORAX

Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study

(2010) David Price et al.   BMC Pulmonary Medicine

X-ray Crystal Structure of the Novel Enhanced-Affinity Glucocorticoid Agonist Fluticasone Furoate in the Glucocorticoid Receptor−Ligand Binding Domain⊥

(2008) Keith Biggadike et al.   JOURNAL OF MEDICINAL CHEMISTRY